BriaCell Therapeutics Corp.
BCTX · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $14 | $1 | $28 | $53 |
| Short-Term Investments | $10 | $0 | $0 | $0 |
| Receivables | $1 | $2 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $7 | $2 |
| Total Curr. Assets | $27 | $5 | $36 | $54 |
| Property Plant & Equip (Net) | $0 | $1 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $2 | $0 | $0 |
| Total NC Assets | $2 | $3 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $30 | $8 | $36 | $55 |
| Liabilities | – | – | – | – |
| Payables | $5 | $10 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $0 | $1 | $1 |
| Total Curr. Liab. | $5 | $10 | $2 | $1 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $2 | $39 | $40 |
| Total NC Liab. | $0 | $2 | $39 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6 | $12 | $41 | $41 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $140 | $100 | $93 | $84 |
| Retained Earnings | -$154 | -$119 | -$108 | -$77 |
| AOCI | $38 | -$0 | -$0 | -$0 |
| Other Equity | $0 | $15 | $10 | $7 |
| Total Equity | $25 | -$3 | -$5 | $13 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$0 | $0 | $0 |
| Total Liab. & Tot. Equity | $30 | $8 | $36 | $55 |
| Net Debt | -$14 | -$1 | -$28 | -$53 |